Huawei Unveils the HUAWEI Mate 10 and HUAWEI Mate 10 Pro
Disruptive innovation often begins with bold dreams. During IFA Berlin, Huawei Consumer Business Group introduced its first AI mobile chipset, the Kirin 970. Today in Munich, Huawei announced the HUAWEI Mate 10 Series, which will open the door to new AI mobile applications. The HUAWEI Mate 10, HUAWEI Mate 10 Pro, and Porsche Design HUAWEI Mate 10 are breakthrough AI devices that combine innovative hardware, the Kirin 970 chipset and EMUI 8.0. The HUAWEI Mate 10 Series continues its legacy of superior product performance and long-lasting battery life, while integrating New Leica Dual Camera technology.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171016005609/en/
The HUAWEI Mate 10 Pro comes in four colors (Photo: Business Wire)
“As we enter the age of intelligence, AI is no longer a virtual concept but something that intertwines with our daily life. AI can enhance user experience, provide valuable services and improve product performance,” said Richard Yu, CEO, Huawei Consumer Business Group. “The HUAWEI Mate 10 Series introduces the first mobile AI-specific Neural Network Processing Unit, launching a new era of intelligent smartphones.”
- Kirin 970, the world’s first AI processor for smartphones with a dedicated Neural Network Processing Unit (NPU);
- A 3D Glass Body featuring a barely-there-bezel, HUAWEI FullView Display and HDR10 supported technology for intensely vivid and brighter colors;
- TÜV Fast-Charge Safety Certified HUAWEI SuperCharge and 4000 mAh battery with AI-powered Battery Management;
- New Leica Dual Camera with SUMMILUX-H lenses, with both featuring an aperture of f/1.6, and intelligent photography including AI-powered Real-Time Scene and Object Recognition and AI-powered Bokeh Effect;
- An all-new EMUI 8.0 based on Android™ 8.0.
A New, Mobile AI Computing Architecture for Intelligent Mobile Experiences
The HUAWEI Mate 10 and HUAWEI Mate 10 Pro are the first devices powered by the new Kirin 970 processor and deliver AI enhancements for a faster, more customized mobile experience. The Kirin 970 features an octa-core ARM Cortex CPU, a first-to-market Mali-G72 12-core GPU and the first NPU designed specifically for a mobile device.
The specialized NPU, combined with Huawei’s HiAI mobile computing platform, means the Kirin 970 delivers 25x better performance and 50x greater energy efficiency for AI-related tasks, compared to four Cortex-A73 cores.¹
Design Qualities for New Levels of Sophistication and Comfort
With an all-new HUAWEI FullView Display, the HUAWEI Mate 10 features a stunning 5.9-inch screen with a 16:9 display, barely-there-bezel and HDR10 to support vivid colors. The 6-inch HUAWEI Mate 10 Pro features an 18:9 OLED display, high screen-to-body ratio and HDR10 for dynamic video viewing.
New Leica Dual Camera and AI-powered Battery Management for the Next Era
Huawei has partnered with Leica to co-engineer the dual-lens camera for the HUAWEI Mate 10 Series. They combine 12-megapixel RGB + 20-megapixel monochrome sensors, Optical Image Stabilization (OIS), dual lenses with a large aperture of f/1.6, AI-powered Bokeh Effect and AI-powered Digital Zoom.
The HUAWEI Mate 10 and HUAWEI Mate 10 Pro pack a 4000 mAh high-density battery featuring a smart battery management system that understands user behaviour and intelligently allocates resources to maximize battery life.
Pricing and Availability
|HUAWEI Mate 10||64GB + 4GB||€699||Late October|
|HUAWEI Mate 10 Pro||
128GB + 6GB
Porsche Design HUAWEI Mate 10
|256GB + 6GB||€1395||Mid-November|
For more information: http://consumer.huawei.com/en/
¹Based on Huawei’s laboratory testing results.
About Huawei Consumer BG
Huawei’s products and services are available in more than 170 countries and are used by a third of the world’s population. Fifteen R&D centers have been set up in the United States, Germany, Sweden, Russia, India and China. Huawei Consumer BG is one of Huawei’s three business units and covers smartphones, PC and tablets, wearables and cloud services, etc. Huawei’s global network is built on almost 30 years of expertise in the telecom industry and is dedicated to delivering the latest technological advances to consumers around the world.
Ben Haber, 617-624-3200
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and